Assay Sheet
Test ID
8700 2009 H1N1 Influenza A Antiviral Resistance
CPT Code
83891, 83894, 83898, 83904 (x2), 83912
Clinical Utility
The emergence of the 2009 H1N1 influenza A virus has lead to increased vigilance in monitoring these infections. Upon proper diagnosis, patients infected with 2009 H1N1 have been effectively treated with oseltamivir. However, oseltamivir-resistant 2009 H1N1 strains have emerged, and incidence is likely to rise due to increased drug exposure and horizontal transmission. Studies have indicated resistance is conferred by a single base mutation (H275Y) in the neuraminidase gene. Utilizing sequencing technology to identify this mutation has proven effective in confirming infections with oseltamivir-resistant 2009 H1N1, allowing physicians to reassess treatment strategies.
Procedure
Extraction of Influenza A nucleic acid from respiratory specimen. Reverse transcription of viral RNA, then amplification of cDNA using conventional PCR followed by gene sequencing. Sequencing analysis provides information on a selected location in the neuraminidase gene implicated in 2009 H1N1 Influenza A antiviral resistance to oseltamivir.
Specimen Type & Specimen Handling
Bronchial Lavage/Bronchial Wash: 2 mls collected in a sterile, screw top tube. Ship at ambient temperature Monday thru Friday. Specimen must be received within 96 hrs of collection.
Sputum: 2 mls collected in a sterile container, then transferred to sterile, screw top tube for shipment. Ship at ambient temperature Monday thru Friday. Specimen must be received within 96 hrs of collection.
Throat Gargle: 2 mls collected in a sterile container then transferred to sterile, screw top tube for shipment. Ship at ambient temperature Monday thru Friday. Specimen must be received within 96 hrs of collection.
Upper respiratory aspirate (NP aspirate, nasal aspirate/wash, tracheal aspirate, etc.): 2 mls collected in a sterile, screw top tube. Ship at ambient temperature Monday thru Friday. Specimen must be received within 96 hrs of collection.
Upper respiratory swab (NP swab, throat swab): Sterile swab placed in 2 ml sterile saline, M4, or viral transport media in a sterile, screw top tube. Do not use calcium alginate swab or wood shafted swab. Ship at ambient temperature Monday thru Friday. Specimen must be received within 96 hrs of collection.
All suction-type collection devices are inappropriate for specimen transport. Transfer specimen into sterile, leakproof tube for transport.
Call ViraCor for authorization prior to sending any specimen type other than those listed above.
Causes for rejection
Wood shafted swab, calcium alginate swab.
Call ViraCor at 800-305-5198 if specimen is greater than 96 hrs old.
Specimen types other than those listed above that were sent without prior authorization.
Specificity
The primers utilized for conventional PCR and sequencing in this assay are specific for 2009 H1N1 Influenza A virus based on similarity search algorithms. Additionally, no cross reactivity was detected when tested against seasonal influenza A subtypes H1N1 and H3N2, influenza B, RSV A, RSV B, parainfluenza 1, parainfluenza 2, parainfluenza 3, hMPV, rhinovirus, and adenovirus.
Assay Range
Qualitative results (Mutation detected at H275Y/None Detected) for antiviral resistance in 2009 H1N1 Influenza A.
Turnaround Time
3 days (Monday through Friday)
Shipping
Ship Monday through Friday. Friday shipments must be labeled for Saturday delivery. All specimens must be labeled with patient's name and collection date. Multiple tests can be run on one specimen.
Ship specimens FedEx Priority Overnight to:
ViraCor Laboratories, 1001 NW Technology Dr, Lee's Summit, MO 64086
The CPT codes provided are based on ViraCor's interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. ViraCor assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material. PCR tests are performed pursuant to a license agreement with Roche Molecular Systems, Inc. This assay was developed and the performance characteristics were determined at ViraCor Laboratories. This test is performed in a CLIA certified laboratory. FDA approval is not required for the performance of this test.
0909 V1